Armata Pharmaceuticals Inc (ARMP)
2.33
-0.35
(-13.06%)
USD |
NYAM |
Nov 15, 14:36
Armata Pharmaceuticals Free Cash Flow (Quarterly): -11.54M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -11.54M |
| March 31, 2024 | -10.83M |
| December 31, 2023 | -10.51M |
| September 30, 2023 | -13.20M |
| June 30, 2023 | -12.28M |
| March 31, 2023 | -19.58M |
| December 31, 2022 | -10.03M |
| September 30, 2022 | -11.63M |
| June 30, 2022 | -9.284M |
| March 31, 2022 | -3.751M |
| December 31, 2021 | -8.826M |
| September 30, 2021 | -5.546M |
| June 30, 2021 | -4.734M |
| March 31, 2021 | -5.773M |
| December 31, 2020 | -6.668M |
| September 30, 2020 | -3.961M |
| June 30, 2020 | -4.129M |
| March 31, 2020 | -4.336M |
| December 31, 2019 | -2.75M |
| September 30, 2019 | -4.502M |
| June 30, 2019 | -5.953M |
| March 31, 2019 | -2.601M |
| December 31, 2018 | -1.51M |
| September 30, 2018 | -2.176M |
| June 30, 2018 | -2.204M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.536M |
| December 31, 2017 | -2.387M |
| September 30, 2017 | -0.626M |
| June 30, 2017 | -2.933M |
| March 31, 2017 | -3.304M |
| December 31, 2016 | -1.511M |
| September 30, 2016 | -3.16M |
| June 30, 2016 | -3.017M |
| March 31, 2016 | -3.197M |
| December 31, 2015 | -2.367M |
| September 30, 2015 | -2.613M |
| June 30, 2015 | -2.671M |
| March 31, 2015 | -2.34M |
| December 31, 2014 | -3.205M |
| September 30, 2014 | -2.764M |
| June 30, 2014 | -3.885M |
| March 31, 2014 | -3.92M |
| December 31, 2013 | -1.417M |
| September 30, 2013 | -2.526M |
| June 30, 2013 | -1.332M |
| March 31, 2013 | -1.119M |
| September 30, 2009 | 1.247M |
| June 30, 2009 | -1.447M |
| March 31, 2009 | -1.30M |
| December 31, 2008 | -3.967M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.58M
Minimum
Mar 2023
-2.75M
Maximum
Dec 2019
-8.387M
Average
-8.826M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -3.237M |
| Perspective Therapeutics Inc | -9.917M |
| Protalix BioTherapeutics Inc | -3.782M |
| Electromed Inc | 4.443M |
| Xtant Medical Holdings Inc | -5.652M |